Du är här


Vårdalinstitutets publikationer

Export 6 results:
Författare Titel [ Typ(Desc)] År
Filtrering: Författare är Johnny Ludvigsson  [Clear All Filters]
Journal Article
Ludvigsson J, Hjorth M, Chéramy M, Axelsson S, Pihl M, Forsander G, m.fl. Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial. Diabetologia [Internet]. 2011;54:634-640. Available from: http://dx.doi.org/10.1007/s00125-010-1988-1
Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, m.fl. GAD treatment and insulin secretion in recent-onset type 1 diabetes. The New England journal of medicine. 2008;359(18):1909-20.
Carlsson A, Forsander G, Ludvigsson J, Larsen S, Örtqvist E. A multicenter observational safety study in Swedish children and adolescents using insulin detemir for the treatment of type 1 diabetes. Pediatric Diabetes [Internet]. 2013;14:358 - 365. Available from: http://ludwig.lub.lu.se/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=23448369&site=eds-live&scope=site
Vaziri-Sani F, Delli AJ, Elding-Larsson H, Lindblad B, Carlsson A, Forsander G, m.fl. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods. 2011;371(1-2):25-37.
Örtqvist E, Björk E, Wallensteen M, Ludvigsson J, Åman J, Johansson C, m.fl. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. Diabetes care. 2004;27(9):2191-7.
Delli AJ, Lindblad B, Carlsson A, Forsander G, Ivarsson S-A, Ludvigsson J, m.fl. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies. Pediatric diabetes. 2010;11(8):513-20.